Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

C. Martínez; C. Canals; B. Sarina; E. P. Alessandrino; D. Karakasis; A. Pulsoni; Simona Sica; M. Trneny; J. A. Snowden; E. Kanfer; N. Milpied; A. Bosi; S. Guidi; C. A. De Souza; R. Willemze; R. Arranz; L. Jebavy; A. Hellmann; D. Sibon; R. Oneto; J. J. Luan; P. Dreger; L. Castagna; A. Sureda

doi:10.1093/annonc/mdt206

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

C. Martínez
, C. Canals
, B. Sarina
, E. P. Alessandrino
, D. Karakasis
, A. Pulsoni
, Simona Sica
, M. Trneny
, J. A. Snowden
, E. Kanfer
, N. Milpied
, A. Bosi
, S. Guidi
, C. A. De Souza
, R. Willemze
, R. Arranz
, L. Jebavy
, A. Hellmann
, D. Sibon
, R. Oneto

J. J. Luan, P. Dreger, L. Castagna, A. Sureda

Hematology, Hospital Clínic
Hematology, Hospital Santa Creu i Sant Pau
IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
IRCCS Fondazione Policlinico San Matteo - Pavia
Evagelismos Hospital
University of Rome La Sapienza
Institute of Hematology and Blood Transfusion
Sheffield Teaching Hospitals NHS Foundation Trust
Hammersmith Hospital
Hopital Haut-Lévêque C.H.U de Bordeaux
Azienda Ospedaliera Careggi
Universidade Estadual de Campinas
Leiden University
Hospital Universitario de la Princesa
Charles University
Medical University of Gdańsk
Université Paris Cité
BMT Registry - GITMO
Sorbonne Université
Heidelberg University

Risultato della ricerca: Contributo in rivista › Articolo

72 Citazioni (Scopus)

Abstract

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.

Lingua originale	Inglese
pagine (da-a)	2430-2434
Numero di pagine	5
Rivista	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume	24
DOI	https://doi.org/10.1093/annonc/mdt206
Stato di pubblicazione	Pubblicato - 2013

Keywords

Hodgkin's lymphoma
autologous stem cell transplantation
relapse

Accesso al documento

10.1093/annonc/mdt206

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Martínez, C., Canals, C., Sarina, B., Alessandrino, E. P., Karakasis, D., Pulsoni, A., Sica, S., Trneny, M., Snowden, J. A., Kanfer, E., Milpied, N., Bosi, A., Guidi, S., De Souza, C. A., Willemze, R., Arranz, R., Jebavy, L., Hellmann, A., Sibon, D., ... Sureda, A. (2013). Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 24, 2430-2434. https://doi.org/10.1093/annonc/mdt206

@article{4da8b19e3a404378be8cfc137d7eab67,

title = "Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation",

abstract = "High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.",

keywords = "Hodgkin's lymphoma, autologous stem cell transplantation, relapse, Hodgkin's lymphoma, autologous stem cell transplantation, relapse",

author = "C. Mart{\'i}nez and C. Canals and B. Sarina and Alessandrino, \{E. P.\} and D. Karakasis and A. Pulsoni and Simona Sica and M. Trneny and Snowden, \{J. A.\} and E. Kanfer and N. Milpied and A. Bosi and S. Guidi and \{De Souza\}, \{C. A.\} and R. Willemze and R. Arranz and L. Jebavy and A. Hellmann and D. Sibon and R. Oneto and Luan, \{J. J.\} and P. Dreger and L. Castagna and A. Sureda",

year = "2013",

doi = "10.1093/annonc/mdt206",

language = "English",

volume = "24",

pages = "2430--2434",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",

}

Martínez, C, Canals, C, Sarina, B, Alessandrino, EP, Karakasis, D, Pulsoni, A, Sica, S, Trneny, M, Snowden, JA, Kanfer, E, Milpied, N, Bosi, A, Guidi, S, De Souza, CA, Willemze, R, Arranz, R, Jebavy, L, Hellmann, A, Sibon, D, Oneto, R, Luan, JJ, Dreger, P, Castagna, L & Sureda, A 2013, 'Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation', Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 24, pagg. 2430-2434. https://doi.org/10.1093/annonc/mdt206

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation. / Martínez, C.; Canals, C.; Sarina, B. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, 2013, pag. 2430-2434.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

AU - Martínez, C.

AU - Canals, C.

AU - Sarina, B.

AU - Alessandrino, E. P.

AU - Karakasis, D.

AU - Pulsoni, A.

AU - Sica, Simona

AU - Trneny, M.

AU - Snowden, J. A.

AU - Kanfer, E.

AU - Milpied, N.

AU - Bosi, A.

AU - Guidi, S.

AU - De Souza, C. A.

AU - Willemze, R.

AU - Arranz, R.

AU - Jebavy, L.

AU - Hellmann, A.

AU - Sibon, D.

AU - Oneto, R.

AU - Luan, J. J.

AU - Dreger, P.

AU - Castagna, L.

AU - Sureda, A.

PY - 2013

Y1 - 2013

N2 - High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.

AB - High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL). However, there is currently little information on the predictors of outcome for patients whose disease recurs after ASCT.

KW - Hodgkin's lymphoma

KW - autologous stem cell transplantation

KW - relapse

KW - Hodgkin's lymphoma

KW - autologous stem cell transplantation

KW - relapse

UR - http://hdl.handle.net/10807/50971

U2 - 10.1093/annonc/mdt206

DO - 10.1093/annonc/mdt206

M3 - Article

VL - 24

SP - 2430

EP - 2434

JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

JF - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

ER -

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo